novel transcript, antisense to Neuregulin 2 (null)

"Novel transcript, antisense to Neuregulin 2" refers to a natural antisense RNA (NAT) that is transcribed from the opposite DNA strand of the Neuregulin 2 gene (NRG2). NATs are typically non-protein-coding RNAs that can regulate the expression of their corresponding "sense" (protein-coding) gene at multiple levels, including transcription, mRNA stability, alternative splicing, and epigenetic modification. Functional NATs may interact with their sense transcripts or with chromatin to mediate positive or negative regulation of gene expression. Most NATs, including this one, are not direct therapeutic targets, do not encode proteins, and are not classified as receptors, enzymes, or other canonical drug targets. While NATs have emerged as key elements in gene regulation and may have roles in disease through their regulatory functions, there is no specific evidence that this transcript is associated with any human disease, nor are there drugs targeting it directly[1][2][3].

Other names

antisense to NRG2NRG2-AS (provisional, not established)

Transcriptional interference RNA masking Epigenetic regulation (e.g., DNA methylation, chromatin modification) Double-stranded RNA (dsRNA)-dependent mechanisms[1][2][3]